Surendra K. Rajpurohit
Papers
2
Total Citations
150
H-Index
2
About
Surendra K. Rajpurohit is a pioneer in whole-organism drug discovery, specializing in high-throughput in vivo screening and pancreatic β-cell biology. His major contributions center on overcoming the limitations of traditional in vitro assays by developing innovative platforms that enable chemical screening in living organisms. His landmark 2015 study, cited over 100 times, introduced the first quantitative high-throughput screen in zebrafish, identifying novel pathways to increase pancreatic β-cell mass—a breakthrough with profound implications for diabetes research. Rajpurohit further advanced the field with his 2016 work on ARQiv-HTS, a versatile whole-organism screening platform that achieves high-throughput rates in vivo, cited 50 times. These achievements demonstrate his ability to bridge the gap between in vitro throughput and physiological relevance, accelerating drug discovery for metabolic diseases. His work has been instrumental in establishing zebrafish as a robust model for preclinical screening, earning recognition for its translational impact. Rajpurohit’s research continues to inspire new approaches in chemical biology and regenerative medicine, offering powerful tools for identifying therapeutic compounds that modulate complex biological systems.
Research Focus
Key Achievements
Top Papers
- 1
- 2